Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Lack of peptide YY immunoreactivity in adenomatous colonic polyps: evidence in favor of an adenoma-carcinoma sequence.

Adrian TE, Ballantyne GH, Zucker KA, Zdon MJ, Tierney R, Modlin IM.

J Surg Res. 1988 May;44(5):561-5.

PMID:
3374119
2.

Colonic chicken-skin mucosa in children with polyps is not a preneoplastic lesion.

Nowicki MJ, Bishop PR, Subramony C, Wyatt-Ashmead J, May W, Crawford M.

J Pediatr Gastroenterol Nutr. 2005 Nov;41(5):600-6.

PMID:
16254516
3.

Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel.

Ponz de Leon M, Roncucci L, Di Donato P, Tassi L, Smerieri O, Amorico MG, Malagoli G, De Maria D, Antonioli A, Chahin NJ, et al.

Cancer Res. 1988 Jul 15;48(14):4121-6.

4.

Pathology of colorectal cancer.

Ponz de Leon M, Di Gregorio C.

Dig Liver Dis. 2001 May;33(4):372-88. Review.

PMID:
11432519
5.

Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.

Ho SB, Ewing SL, Montgomery CK, Kim YS.

Oncol Res. 1996;8(2):53-61.

PMID:
8859775
6.

Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa.

Ramsay RG, Thompson MA, Hayman JA, Reid G, Gonda TJ, Whitehead RH.

Cell Growth Differ. 1992 Oct;3(10):723-30.

7.

Plasma and tissue alterations of peptide YY and enteroglucagon in rats after colectomy.

Vukasin AP, Ballantyne GH, Nilsson O, Bilchik AJ, Adrian TE, Modlin IM.

Yale J Biol Med. 1992 Jan-Feb;65(1):1-15.

8.

Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon.

Flohil CC, Janssen PA, Bosman FT.

J Pathol. 1996 Apr;178(4):393-7.

PMID:
8691316
9.

Peptide YY-like immunoreactivity in normal colon mucosa, muscle layer and adenocarcinoma.

Tari A, Miyachi Y, Sumii K, Kajiyama G, Miyoshi A.

Jpn J Med. 1987 May;26(2):184-8.

10.

Proliferative activity of normal and neoplastic colonic mucosa in population groups with high and low risk for colorectal carcinoma.

Jaskiewicz K, Lancaster E, Banach L, Karmolinski A.

Anticancer Res. 1998 Nov-Dec;18(6B):4641-4.

PMID:
9891533
11.

Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY.

Schmidt PT, Ljung T, Hartmann B, Hare KJ, Holst JJ, Hellström PM.

Eur J Gastroenterol Hepatol. 2005 Feb;17(2):207-12.

PMID:
15674099
12.

Epithelial cell folate depletion occurs in neoplastic but not adjacent normal colon mucosa.

Meenan J, O'Hallinan E, Scott J, Weir DG.

Gastroenterology. 1997 Apr;112(4):1163-8.

PMID:
9097999
13.

Immunohistochemical study of decorin expression in polyps and carcinomas of the colon.

Augoff K, Rabczynski J, Tabola R, Czapla L, Ratajczak K, Grabowski K.

Med Sci Monit. 2008 Oct;14(10):CR530-5.

PMID:
18830193
14.
15.

Isolation and sequencing of a novel tropomyosin isoform preferentially associated with colon cancer.

Lin JL, Geng X, Bhattacharya SD, Yu JR, Reiter RS, Sastri B, Glazier KD, Mirza ZK, Wang KK, Amenta PS, Das KM, Lin JJ.

Gastroenterology. 2002 Jul;123(1):152-62.

PMID:
12105844
16.

Localization and expression of p27KIP1 in multistage colorectal carcinogenesis.

Ciaparrone M, Yamamoto H, Yao Y, Sgambato A, Cattoretti G, Tomita N, Monden T, Rotterdam H, Weinstein IB.

Cancer Res. 1998 Jan 1;58(1):114-22.

17.

[The malignancy potential of colorectal polyps--histomorphometric, histochemical and immunohistochemical study of the dysplasia-carcinoma sequence].

Dippe B, Petrowsky H, Krüger S, von Jentzkowski K, Schneider M, Lorenz M.

Zentralbl Chir. 1995;120(7):556-63. German.

PMID:
7676754
19.

Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.

Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC.

Cancer Res. 1996 May 15;56(10):2422-7.

20.

Supplemental Content

Support Center